Beyond the opportunities of SDG 3: The risk for the NCDs agenda

The Lancet Diabetes and Endocrinology

Volumn 4, Issue 1, 2016, Pages 15-17

  Ordunez, Pedro ^a   Campbell, Norm RC ^b  

^a PAN AMERICAN HEALTH ORGANIZATION   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL ABUSE; CARDIOVASCULAR DISEASE; EBOLA HEMORRHAGIC FEVER; ELEVATED BLOOD PRESSURE; ENVIRONMENTAL FACTOR; EPIDEMIC; HEALTH CARE ACCESS; HEALTH CARE PLANNING; HEALTH DISPARITY; HEALTH HAZARD; HEALTH INSURANCE; HEALTH PROMOTION; HEALTH STATUS; HUMAN; HYPERTENSION; MORTALITY; NON COMMUNICABLE DISEASE; NOTE; POVERTY; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; SUBSTANCE ABUSE; SUSTAINABLE DEVELOPMENT; SUSTAINABLE DEVELOPMENT GOAL; TOBACCO USE; TRAFFIC; WELLBEING; CHRONIC DISEASE; DEVELOPING COUNTRY; GLOBAL HEALTH; HEALTH CARE POLICY;

CHRONIC DISEASE; DEVELOPING COUNTRIES; GLOBAL HEALTH; HEALTH POLICY; HUMANS;

EID: 84955382914     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(15)00488-X     Document Type: Note

References (19)

1. Transforming our world: the 2030 Agenda for Sustainable Development. The 2030 Agenda for sustainable development. A/RES/70/1 2015, UN, United Nations, New York, (accessed Nov 20, 2015). https://sustainabledevelopment.un.org/content/documents/21252030%20Agenda%20for%20Sustainable%20Development%20web.pdf.
2. The Millennium Development Goals Report 2015 2015, United Nations, United Nations, New York, (accessed Nov 20, 2015). http://www.un.org/millenniumgoals/2015_MDG_Report/pdf/MDG%202015%20rev%20(July%201).pdf.
3. Sixty-sixth Sessions. Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. A/66/L.1 2011 Sep 16, United Nations General Assembly, United Nations, New York, (accessed Nov 20, 2015). http://www.un.org/es/comun/docs/?symbol=A/66/L.1.
4. Bloom DE, Cafiero ET, Jané-Llopis E, et al. The Global Economic Burden of Noncommunicable Diseases 2011, World Economic Forum, Geneva.
5. Draft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases. 66th World Health Assembly; 15 March 2013. Document A66/8 WHO, (accessed Nov 20, 2015). http://bit.ly/IZZ4XM.
6. Pearce N, Ebrahim S, McKee M, et al. Global prevention and control of NCDs: Limitation of the standard approach. J Public Health Policy 2015, 26:1-18.
7. Scaling up action against noncommunicable diseases: how much will it cost? 2011, WHO, World Health Organization, Geneva, (accessed Nov 20, 2015). http://apps.who.int/iris/bitstream/10665/44706/1/9789241502313_eng.pdf.
8. Schmidt H, Barnhill A Equity and noncommunicable disease reduction under the Sustainable Development Goals. PLoS Med 2015, 12:e1001872.
9. Kontis V, Mathers CD, Bonita R, et al. Regional contributions of six preventable risk factors to achieving the 25 × 25 non-communicable disease mortality reduction target: a modelling study. Lancet Glob Health 2015, published online Oct 21. http://dx.doi.org/10.1016/S2214-109X(15)00179-5.
10. Reddy KS Regional roadmaps for reducing premature deaths from NCDs. Lancet Global Health 2015, published online Oct 21. http://dx.doi.org/10.1016/S2214-109X(15)00212-0.
11. Bukhman G, Mocumbi AO, Horton R Reframing NCDs and injuries for the poorest billion: a Lancet Commission. Lancet 2015, 386:1221-1222.
12. Bukhman G, Bavuma C, Gishoma C, et al. Endemic diabetes in the world's poorest people. Lancet Diabetes Endocrinol 2015, 3:402-403.
13. Ordunez P, Prieto-Lara E, Pinheiro Gawryszewski V, Hennis AJM, Cooper RS Premature Mortality from Cardiovascular Disease in the Americas-Will the Goal of a Decline of "25 by 2025" be Met?. PLoS One 2015, 10:e0141685.
14. Adler A, Prabhakaran D, Bovet P, et al. Reducing cardiovascular mortality through prevention and management of raised blood pressure. A World Heart Federation Roadmap. Glob Heart 2015, 10:111-122.
15. McAlister FA, Wilkins K, Joffres M, et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ 2011, 183:1007-1013.
16. Ordunez P, Campbell N Global health metrics and non-communicable diseases: the case of hypertension. Lancet Diabetes Endocrinol 2015, 3:763.
17. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013, 380:2197-3123.
18. Global health metrics and NCDs: are our perceptions years behind the data?. Lancet Diabetes Endocrinol 2015, 3:577. Lancet Diabetes & Endocrinology.
19. Monitoring progress in NCDs: key to accountability. Lancet Diabetes Endocrinol 2015, 3:159. Lancet Diabetes & Endocrinology.